What is the best initial test for pulmonary embolism (PE) in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Test for Pulmonary Embolism in Pregnancy

The best initial test depends on clinical presentation: perform chest X-ray first in all cases, then if signs/symptoms of DVT are present, start with bilateral lower extremity compression ultrasound; if no DVT signs and chest X-ray is normal, proceed with lung scintigraphy (V/Q scan); if chest X-ray is abnormal, proceed with CT pulmonary angiography (CTPA). 1, 2

Initial Clinical Assessment and Triage

Start with chest radiography (CXR) as the first radiation-associated procedure to guide subsequent imaging choices and minimize radiation exposure. 1, 2 This strong recommendation from the American Thoracic Society helps triage between V/Q scanning and CTPA based on whether the CXR is normal or abnormal. 1

If DVT Signs/Symptoms Present

Perform bilateral compression ultrasound (CUS) of lower extremities first if the patient has leg swelling, pain, or other DVT symptoms. 1, 2 This approach prioritizes avoiding radiation exposure when possible:

  • If CUS is positive: initiate anticoagulation immediately without further pulmonary imaging 1
  • If CUS is negative: proceed to chest radiography and then pulmonary vascular imaging 1

The "LEFt" criteria can help identify high-risk patients: symptoms in the Left leg, calf circumference difference >2 cm, and First trimester presentation predict DVT in 58.3% of cases when 2-3 variables are present. 1

If No DVT Signs/Symptoms

Proceed directly to pulmonary vascular imaging rather than lower extremity ultrasound to improve cost-effectiveness and diagnostic efficiency. 1

Pulmonary Vascular Imaging Selection

Normal Chest X-Ray: Choose V/Q Scan

Lung scintigraphy (V/Q scan) is preferred over CTPA when the chest X-ray is normal. 1, 2 This strong recommendation is based on:

  • Lower maternal breast radiation: V/Q delivers 0.28-0.37 mGy to breast tissue versus 44 mGy with CTPA 3
  • Diagnostic yield: 75-94% of V/Q scans provide diagnostic results (high probability, very low probability, or normal) in pregnant women with normal CXR 1
  • Similar accuracy: False-negative rates are comparable between V/Q (0.5%) and CTPA (0.4%) 4
  • Fetal safety: Both modalities deliver fetal radiation well below the 50,000 μGy safety threshold 1

The lifetime breast cancer risk increase from a single CTPA in a 25-year-old woman is 1.011, making radiation minimization important. 2

Abnormal Chest X-Ray: Choose CTPA

CTPA is preferred over V/Q scanning when the chest X-ray is abnormal because V/Q scans lose accuracy in the presence of parenchymal lung disease. 2, 4 CTPA also provides the advantage of identifying alternative diagnoses. 2

Important Caveats and Pitfalls

D-Dimer Testing

Do not use D-dimer to exclude PE in pregnancy. 1 The American Thoracic Society gives this a weak recommendation with very-low-quality evidence, but emphasizes avoiding false negatives. D-dimer levels rise physiologically throughout pregnancy, with only 4.2% of third-trimester women with non-high pre-test probability having negative D-dimer. 5

Technical Challenges with CTPA

CTPA yields inconclusive results in 6-36% of pregnant women due to suboptimal vascular opacification and respiratory motion artifacts. 2 In the third trimester specifically, 43% of studies may be inconclusive. 5 Optimize CTPA protocols with:

  • Automated bolus triggering
  • High iodine flux and concentration
  • Reduced anatomical coverage
  • Iterative reconstruction techniques 2, 5

Avoid repeated CTPA after non-diagnostic studies due to cumulative radiation exposure. 2

Management of Inconclusive Results

Initiate empiric anticoagulation while awaiting further testing if clinical suspicion is high and an initial imaging study is inconclusive or unavailable. 2, 4 PE accounts for 20% of maternal deaths in the United States, making the risk-benefit ratio favor treatment during diagnostic uncertainty. 4

For indeterminate CTPA results:

  • Assess for DVT symptoms and perform bilateral CUS if present 4
  • Consider V/Q scanning if chest X-ray was normal 4
  • Start therapeutic low-molecular-weight heparin if clinical suspicion remains high 4

Contrast Agent Safety

Iodinated contrast agents for CTPA are not associated with neonatal adverse events and should not be withheld due to fetal concerns. 6 Modern CTPA techniques deliver fetal radiation doses well below complication thresholds (actual doses <1 mGy versus 50-100 mSv threshold). 5

Algorithm Summary

  1. All patients: Obtain chest X-ray first 1, 2
  2. DVT signs/symptoms present: Bilateral lower extremity CUS → if positive, treat; if negative, proceed to step 3 1
  3. Normal CXR: V/Q scan 1, 2
  4. Abnormal CXR: CTPA 2, 4
  5. Inconclusive or unavailable imaging with high suspicion: Empiric anticoagulation 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach for Pulmonary Embolism in Pregnant Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Pregnant Patients with Indeterminate CT Scan for Pulmonary Embolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Risks of CTPA During the 3rd Trimester of Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.